The in vitro activity of tedizolid against multidrug-resistant (MDR) pneumococci from geographically diverse Asian areas was evaluated.
Tedizolid was highly active against MDR pneumococci.
Tedizolid also maintained the activity against extensively drug-resistant (XDR) S. pneumoniae.